The Form 4 filing, an SEC report of an insider's stock trades, was filed on November 12, 2026. The sale took place on November 9, three days before the filing date.
The report lists Kenneth A. Burdick as a director of LifeStance Health Group (LFST). The company is listed in the healthcare sector under medical care facilities.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-09 |
| Date of Latest Transaction | 2026-11-09 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 66,589 |
| Price | $14.41 |
| Total Transaction Value | $959,547.49 |
| Insider | |
| Ticker Symbol | LFST |
| Company | LifeStance Health Group, Inc. |
| Insider Name | Burdick Kenneth A |
| Insider Title | Director |
| Sector - Industry | Healthcare - Medical Care Facilities |
| Holdings | |
| Total Shares Owned After Transaction | 2,904,221 |
| Position Size Change | 2.24% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of company shares, reported with transaction code S. The filing lists one sale transaction for Kenneth A. Burdick.
What was the average price of the transaction?
The average sale price was $14.41 per share. This is the reported price for the single transaction involving 66,589 shares.
How did this transaction affect the insider's holdings?
Kenneth A. Burdick sold 66,589 shares and reported owning 2,904,221 shares afterward. The shares sold made up 2.24% of the shares he owned before the sale.
What's the total transaction value?
The total transaction value was $959,547.49. That amount covers the one reported sale on November 9, 2026.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement. Footnote text was not available for this report, so further terms or explanations remain unknown.
For research purposes only; not investment advice.